---name: antibody-design-agent description: An advanced agent for de novo antibody design and optimization using state-of-the-art protein language models (MAGE, RFdiffusion). license: MIT metadata: author: VUMC / UW Baker Lab version: "1.0.0" compatibility: - system: Python 3.10+ - hardware: GPU required (A100/H100) allowed-tools: - run_shell_command keywords: - antibody-design - automation - biomedical measurable_outcome: execute task with >95% success rate. ---" # Antibody Design Agent This skill brings together cutting-edge tools for antibody engineering, including MAGE (Monoclonal Antibody Generator) and RFdiffusion for Antibodies. It enables the de novo design of antibodies against specific viral or tumoral targets. ## When to Use This Skill * **De Novo Design**: Generating antibody sequences/structures that bind to a specific antigen. * **Epitope Targeting**: Designing VHH or binders for a specific epitope on a target protein. * **Optimization**: Improving the affinity or stability of an existing antibody candidate. * **Viral Defense**: Rapidly generating antibodies against novel viral strains. ## Core Capabilities 1. **MAGE (Monoclonal Antibody Generator)**: Uses a protein language model to generate diverse antibody sequences against unseen viral strains. 2. **RFdiffusion for Antibodies**: Generates 3D antibody structures that bind to a target structure with high precision. 3. **ProteinMPNN**: Optimizes the sequence of the generated structures for solubility and expression. ## Workflow 1. **Target Definition**: Input the PDB structure or sequence of the antigen (target). 2. **Design Phase**: * Use **RFdiffusion** to generate the backbone of the binder (CDR loops). * Use **ProteinMPNN** to design the sequence for the backbone. * *Alternatively*, use **MAGE** to generate sequences directly from viral strain data. 3. **Validation (In Silico)**: Use AlphaFold3 or ESMFold to predict the complex structure and assess binding confidence (pLDDT, PAE). 4. **Selection**: Rank candidates for synthesis. ## Example Usage **User**: "Design a VHH nanobody that binds to the RBD of the SARS-CoV-2 KP.2 variant." **Agent Action**: 1. Retrieves RBD structure for KP.2. 2. Runs `RFdiffusion` with "binder" constraints on the RBD surface. 3. Generates 100 backbone candidates. 4. Sequences them with `ProteinMPNN`. 5. Folds the complexes with `AlphaFold3` to verify binding interface. 6. Returns top 5 sequences.